Case report: C-reactive protein apheresis in cardiogenic shock: case series from the C-reactive protein apheresis in acute myocardial infarction-registry

J. Torzewski; S. Mattecka; W. Ries; C. D. Garlichs; F. Heigl; J. Fiedler; A. Sheriff; A. Sheriff

doi:10.3389/fddsv.2023.1286710

Frontiers in Drug Discovery (Dec 2023)

Case report: C-reactive protein apheresis in cardiogenic shock: case series from the C-reactive protein apheresis in acute myocardial infarction-registry

J. Torzewski,
S. Mattecka,
W. Ries,
C. D. Garlichs,
F. Heigl,
J. Fiedler,
A. Sheriff,
A. Sheriff

Affiliations

J. Torzewski: Cardiovascular Center Oberallgaeu-Kempten, Clinic Association Allgaeu, Kempten, Germany
S. Mattecka: Pentracor GmbH, Hennigsdorf, Germany
W. Ries: Diakonissenhospital Flensburg, Flensburg, Germany
C. D. Garlichs: Diakonissenhospital Flensburg, Flensburg, Germany
F. Heigl: Medical Care Center Kempten-Allgaeu, Kempten, Germany
J. Fiedler: Cardiovascular Center Oberallgaeu-Kempten, Clinic Association Allgaeu, Kempten, Germany
A. Sheriff: Pentracor GmbH, Hennigsdorf, Germany
A. Sheriff: Department of Gastroenterology/Infectiology/Rheumatology, Charité University Medicine Berlin, Berlin, Germany

DOI: https://doi.org/10.3389/fddsv.2023.1286710
Journal volume & issue: Vol. 3

Abstract

Read online

C-reactive protein (CRP) apheresis may preserve myocardial tissue after acute myocardial infarction with delayed revascularization. Ten consecutive patients with cardiogenic shock were graded using the Society of Cardiovascular Angiography and Interventions shock classification and treated with CRP apheresis. All patients tolerated CRP apheresis well and were discharged in good clinical condition.

Published in Frontiers in Drug Discovery

ISSN: 2674-0338 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://www.frontiersin.org/journals/drug-discovery

About the journal

Abstract

Keywords